Case Comprehensive Cancer Center: Colorectal Neoplasms trials

The registry lists 12 Colorectal Neoplasms studies with Case Comprehensive Cancer Center as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)Not yet recruitingNCT07219745Not applicable
• Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver MetastasisRecruitingNCT07044362Not applicable
• Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)Not yet recruitingNCT06811454Not applicable
• The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer SurvivorsRecruitingNCT04624555
• Educate, Assess Risk and Overcoming Barriers to Colorectal Screening Among African AmericansCompletedNCT03640208Not applicable
• Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal CancerWithdrawnNCT03307603Phase 1/2
• Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal CancerCompletedNCT00856115
• Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
• Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
• Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal CancerCompletedNCT00118261Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00005981Phase 2
• Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal CancerCompletedNCT00002933Phase 2